607 related articles for article (PubMed ID: 18556574)
21. Apolipoprotein C-III: understanding an emerging cardiovascular risk factor.
Ooi EM; Barrett PH; Chan DC; Watts GF
Clin Sci (Lond); 2008 May; 114(10):611-24. PubMed ID: 18399797
[TBL] [Abstract][Full Text] [Related]
22. Lipid and lipoprotein metabolism in chronic kidney disease.
Kaysen GA
J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
[TBL] [Abstract][Full Text] [Related]
23. [Disorders of lipid metabolism in insulin resistance].
Müller-Wieland D; Krone W
Herz; 1995 Feb; 20(1):33-46. PubMed ID: 7713475
[TBL] [Abstract][Full Text] [Related]
24. Insulin and HDL-cholesterol metabolism.
Fossati P; Romon-Rousseaux M
Diabete Metab; 1987 Jul; 13(3 Pt 2):390-4. PubMed ID: 3308570
[TBL] [Abstract][Full Text] [Related]
25. Hepatic heparan sulfate proteoglycans and endocytic clearance of triglyceride-rich lipoproteins.
Foley EM; Esko JD
Prog Mol Biol Transl Sci; 2010; 93():213-33. PubMed ID: 20807647
[TBL] [Abstract][Full Text] [Related]
26. Lipid and lipoprotein dysregulation in insulin resistant states.
Avramoglu RK; Basciano H; Adeli K
Clin Chim Acta; 2006 Jun; 368(1-2):1-19. PubMed ID: 16480697
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of action of niacin.
Kamanna VS; Kashyap ML
Am J Cardiol; 2008 Apr; 101(8A):20B-26B. PubMed ID: 18375237
[TBL] [Abstract][Full Text] [Related]
28. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
[TBL] [Abstract][Full Text] [Related]
29. Development of lipoprotein-like lipid particles for drug targeting: neo-high density lipoproteins.
Schouten D; van der Kooij M; Muller J; Pieters MN; Bijsterbosch MK; van Berkel TJ
Mol Pharmacol; 1993 Aug; 44(2):486-92. PubMed ID: 8355672
[TBL] [Abstract][Full Text] [Related]
30. A novel efflux-recapture process underlies the mechanism of high-density lipoprotein cholesteryl ester-selective uptake mediated by the low-density lipoprotein receptor-related protein.
Vassiliou G; McPherson R
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1669-75. PubMed ID: 15178567
[TBL] [Abstract][Full Text] [Related]
31. Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model.
Balazs Z; Panzenboeck U; Hammer A; Sovic A; Quehenberger O; Malle E; Sattler W
J Neurochem; 2004 May; 89(4):939-50. PubMed ID: 15140193
[TBL] [Abstract][Full Text] [Related]
32. Ritonavir impairs lipoprotein lipase-mediated lipolysis and decreases uptake of fatty acids in adipose tissue.
den Boer MA; Berbée JF; Reiss P; van der Valk M; Voshol PJ; Kuipers F; Havekes LM; Rensen PC; Romijn JA
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):124-9. PubMed ID: 16269669
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants.
Grosskopf I; Baroukh N; Lee SJ; Kamari Y; Harats D; Rubin EM; Pennacchio LA; Cooper AD
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2573-9. PubMed ID: 16166565
[TBL] [Abstract][Full Text] [Related]
34. Effect of alcohol on lipoprotein metabolism. I. High density lipoprotein binding.
Parkes JG; Hussain RA; Goldberg DM
Clin Physiol Biochem; 1989; 7(6):269-77. PubMed ID: 2560688
[TBL] [Abstract][Full Text] [Related]
35. Identification of novel human high-density lipoprotein receptor Up-regulators using a cell-based high-throughput screening assay.
Yang Y; Zhang Z; Jiang W; Gao L; Zhao G; Zheng Z; Wang M; Si S; Hong B
J Biomol Screen; 2007 Mar; 12(2):211-9. PubMed ID: 17259591
[TBL] [Abstract][Full Text] [Related]
36. Impact of vitamin A on high-density lipoprotein-cholesterol and scavenger receptor class BI in the obese rat.
Jeyakumar SM; Vajreswari A; Giridharan NV
Obesity (Silver Spring); 2007 Feb; 15(2):322-9. PubMed ID: 17299104
[TBL] [Abstract][Full Text] [Related]
37. Role of apolipoprotein A-IV in hepatic lipase-catalyzed dolichol acylation and phospholipid hydrolysis.
Sindelar PJ; Chojnacki I; Valtersson C
Biochemistry; 1997 Feb; 36(7):1807-13. PubMed ID: 9048565
[TBL] [Abstract][Full Text] [Related]
38. Lipoprotein electrostatic properties regulate hepatic lipase association and activity.
Boucher JG; Nguyen T; Sparks DL
Biochem Cell Biol; 2007 Dec; 85(6):696-708. PubMed ID: 18059528
[TBL] [Abstract][Full Text] [Related]
39. High-density lipoproteins: multifunctional vanguards of the cardiovascular system.
Marcil M; O'Connell B; Krimbou L; Genest J
Expert Rev Cardiovasc Ther; 2004 May; 2(3):417-30. PubMed ID: 15151487
[TBL] [Abstract][Full Text] [Related]
40. Disorders in high-density metabolism with insulin resistance and chronic kidney disease.
Kaysen GA
J Ren Nutr; 2007 Jan; 17(1):4-8. PubMed ID: 17198924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
